Company Profile
H.U. Group Holdings, Inc., operates healthcare business globally. The Lab Testing and Its Related Services segment provides general testing services to medical institutions that include esoteric testing, such as genetic and oncology testing.
Its portfolio also includes companion diagnostics-related tests for cancer treatment, omics analysis comprising whole genome sequencing and proteome analysis, and comprehensive support for clinical trials and research
Including pre-trial setup work, specimen collection and transport, measuring, result reports, and data management, as well as SaaS for general practitioners and personal health records.
Its In-Vitro Diagnostics segment provides Lumipulse system products, an automated chemiluminescence enzyme immunoassay system that offers reagents. Its portfolio also includes testing services for neurodegenerative diseases, and rapid diagnostics kit for infectious diseases comprising influenza and COVID-19
Cerebrospinal fluid reagent. This segment also develops blood-based reagents and biomarkers specifically for neurodegenerative diseases, such as Alzheimer's. The Healthcare-related Services segment offers in-house sterilization for central supply rooms in hospitals and external sterilization at sterilization centers.
Its portfolio also includes operating room support, endoscopy room support, medical equipment maintenance and inspection, and logistics management and transportation services, support for important tasks related to hospital administration work
Including the sale of medical equipment, supplies, and consumables related to central supply rooms and operating rooms, bulk rentals of nursing care equipment, supplying equipment including wheelchairs and nursing beds, and home medical care and nursing services.
Group Holdings, Inc. in July 2020. H.U. The company was formerly known as Miraca Holdings Inc. and changed its name to H.U. Incorporated in 1950, Group is headquartered in Tokyo, Japan.